Pharmaceutical Services

SAI MedPartners Enhances Its Competitive Intelligence Capabilities through the Acquisition of The Dunn Group

SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired The Dunn Group (“TDG”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022. TDG, headquartered in Totowa, NJ, is a competitive intelligence firm that […]

SAI MedPartners Enhances Its Competitive Intelligence Capabilities through the Acquisition of The Dunn Group Read More »

Monroe Biomedical Research Acquires L-MARC to Expand Therapeutic Expertise and Geographic Footprint

Monroe Biomedical Research (“MBR”), a leading clinical trial site network specializing in patient recruitment for complex clinical trials, has completed the acquisition of L-MARC (Louisville Metabolic and Atherosclerosis Research Center, Inc.), a nationally recognized clinical research site based in Louisville, Kentucky. Founded by Dr. Harold Bays, L-MARC has built a strong reputation for excellence in

Monroe Biomedical Research Acquires L-MARC to Expand Therapeutic Expertise and Geographic Footprint Read More »

Paradigm Health Acquires Flatiron Health’s Clinical Research Business and Forms Strategic Partnership to Rebuild Clinical Research Ecosystem

Paradigm Health and Flatiron Health announces that Paradigm Health will acquire Flatiron’s Clinical Research Business. The transaction includes the industry’s most extensive tech-enabled U.S. oncology research network and Flatiron’s suite of clinical research solutions, and establishes a multi-year collaboration between the two organizations to maximize the benefits for providers, sponsors, and patients. Through this transaction,

Paradigm Health Acquires Flatiron Health’s Clinical Research Business and Forms Strategic Partnership to Rebuild Clinical Research Ecosystem Read More »

CRO Consolidation: How Mergers Impact Clinical Trials

Under intense cost and efficiency pressures, the pharmaceutical industry has increasingly outsourced clinical trial work to contract research organizations (CROs). Over the past decade this has led to unprecedented consolidation in the CRO sector. Dozens of mergers and acquisitions (M&A) have created global “one-stop” research giants, but also raised questions about cost, quality, and competition.

CRO Consolidation: How Mergers Impact Clinical Trials Read More »

Q3 2025 Pharma Services Market Update

Private equity deal activity sharply softened in 2025 across all of pharma services. Bourne Partners attribute this softness to the lagged capital markets impact of the Federal Reserve sharply raising interest rates in 2022 and 2023 — as well as the ongoing impact of the Inflation Reduction Act (IRA) of 2022, the One Big Beautiful

Q3 2025 Pharma Services Market Update Read More »

Scroll to Top